Skip to main content
. 2018 Oct 15;3(2):229–235. doi: 10.1007/s41669-018-0098-8
The data suggest that hospitalisations for relapsed/refractory acute lymphoblastic leukaemia are common in Spain and often last for several weeks.
Such hospital admissions are associated with high costs.